| Literature DB >> 24758592 |
Antonello Di Nardo1, Davide Rossi, Saleh M Lamin Saleh, Saleh M Lejlifa, Sidumu J Hamdi, Annapia Di Gennaro, Giovanni Savini, Michael V Thrusfield.
Abstract
BACKGROUND: The increasing global importance of Rift Valley fever (RVF) is clearly demonstrated by its geographical expansion. The presence of a wide range of host and vector species, and the epidemiological characteristics of RVF, have led to concerns that epidemics will continue to occur in previously unaffected regions of Africa. The proximity of the Sahrawi territories of Western Sahara to endemic countries, such as Mauritania, Senegal, and Mali with periodic isolation of virus and serological evidence of RVF, and the intensive livestock trade in the region results in a serious risk of RVF spread in the Sahrawi territories, and potentially from there to the Maghreb and beyond. A sero-epidemiological survey was conducted in the Saharawi territories between March and April 2008 to investigate the possible presence of the RVF virus (RVFV) and associated risk factors. A two-stage cluster sampling design was used, incorporating 23 sampling sites.Entities:
Mesh:
Year: 2014 PMID: 24758592 PMCID: PMC4003290 DOI: 10.1186/1746-6148-10-92
Source DB: PubMed Journal: BMC Vet Res ISSN: 1746-6148 Impact factor: 2.741
Figure 1Geographical allocation of the study area.
Proportional allocation of calculated sample size by animal species (95% CI, 5% , 15% , 0.0039 )
| Sheep | 62681 | 443.1 | 40.3 |
| Goats | 51649 | 443.8 | 40.3 |
| Camels | 26175 | 447.5 | 40.7 |
| 140505 | 1334.4 | 121.3 |
Observed and true Rift Valley fever animal prevalence, associated exact 95% Confidence interval for two-stage cluster sampling and within sampling site prevalence by region
| Wilayas | 4/356 | 0.92 [0.95] | 0.25 – 3.38 | 0 – 2.47 |
| Bir Lehlou | 1/90 | 0.69 [0.70] | 0.09 – 4.83 | 0 – 1.14 |
| Tifariti | 4/89 | 4.96 [5.29] | 1.88 – 12.44 | 0 – 7.69 |
| Mehaires | 1/84 | 1.22 [1.27] | 0.17 – 8.21 | 0 – 7.14 |
| Mijek | 0/81 | 0 [0] | 0 – 0 | 0 – 0 |
| Agwanit | 0/94 | 0 [0] | 0 – 0 | 0 – 0 |
| Dougaj | 0/85 | 0 [0] | 0 – 0 | 0 – 0 |
| Dahkla | 1/103 | 1.75 [1.84] | 0.24 – 11.48 | 0 – 1.75 |
| 11/982 | 0.97 [1.00] | 0.33 – 2.85 | 0 – 7.69 |
*Adjusted Wald test between region (d.f. 7, 974) (p = 0.0001).
Figure 2Box plot of inhibition-Elisa test results for all species sampled. Percentage of Inhibition values of ≥36.1 for camel (long-dash red line), ≥38.4 for sheep (short-dash red line) and ≥41.4 for goat (dash-dot red line) indicate a positive result.
Figure 3Box plot of inhibition-Elisa test results versus age groups.
Observed and true Rift Valley fever animal prevalence, associated exact 95% Confidence interval for two-stage cluster sampling and within specie prevalence by sampling site
| 1 | 27 Febrero | 2/87 | 2.47 [2.61] | 0.62 – 9.38 | 0 – 4.88 |
| 2 | Smara | 2/92 | 2.35 [2.49] | 0.59 – 8.95 | |
| 3 | Awserd | 0/86 | 0 [0] | 0 – 0 | 0 – 0 |
| 4 | El Aaiun | 0/91 | 0 [0] | 0 – 0 | 0 – 0 |
| 5 | Bir Lehlou | 1/60 | 1.14 [1.19] | 0.16 – 7.79 | 0 – 2.27 |
| 6 | Bir Lehlou | 0/6 | 0 [0] | 0 – 0 | 0 – 0 |
| 7 | Bir Lehlou | 0/10 | 0 [0] | 0 – 0 | 0 – 0 |
| 8 | Bir Lehlou | 0/14 | 0 [0] | 0 – 0 | 0 – 0 |
| 9 | Tifariti | 0/23 | 0 [0] | 0 – 0 | 0 – 0 |
| 10 | Tifariti | 4/61 | 7.69 [8.22] | 2.91 – 18.80 | 0 – 15.38 |
| 11 | Tifariti | 0/5 | 0 [0] | 0 – 0 | 0 – 0 |
| 12 | Mehaires | 0/17 | 0 [0] | 0 – 0 | 0 – 0 |
| 13 | Mehaires | 0/21 | 0 [0] | 0 – 0 | 0 – 0 |
| 14 | Mehaires | 0/15 | 0 [0] | 0 – 0 | 0 – 0 |
| 15 | Mehaires | 1/20 | 7.14 [7.63] | 1.00 – 36.95 | 0 – 14.29 |
| 16 | Mehaires | 0/11 | 0 [0] | 0 – 0 | 0 – 0 |
| 17 | Mijek | 0/15 | 0 [0] | 0 – 0 | 0 – 0 |
| 18 | Mijek | 0/66 | 0 [0] | 0 – 0 | 0 – 0 |
| 19 | Agwanit | 0/38 | 0 [0] | 0 – 0 | 0 – 0 |
| 20 | Agwanit | 0/56 | 0 [0] | 0 – 0 | 0 – 0 |
| 21 | Dougaj | 0/42 | 0 [0] | 0 – 0 | 0 – 0 |
| 22 | Dougaj | 0/43 | 0 [0] | 0 – 0 | 0 – 0 |
| 23 | Dahkla | 1/103 | 1.75 [1.84] | 0.24 – 11.48 | 0 – 5.26 |
| 11/982 | 0.97 [1.00] | 0.33 – 2.85 | 0 – 15.38 |
*Adjusted Wald test between sampling sites (d.f. 22, 974) (p = 0.0001).
Figure 4Observed Rift Valley fever sero-prevalence distribution in the study area.